Immatics Ownership | Who Owns Immatics?
Immatics Ownership Summary
Immatics is owned by 86.40% institutional investors, 22.85% insiders. T. rowe price investment management is the largest institutional shareholder, holding 10.00% of IMTX shares. Vanguard Explorer Inv is the top mutual fund, with 3.08% of its assets in Immatics shares.
IMTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Immatics | 86.40% | 22.85% | -9.25% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
T. rowe price investment management | 10.60M | 10.00% | $75.40M |
Wellington management group llp | 10.42M | 9.83% | $74.07M |
Perceptive advisors | 9.38M | 8.85% | $66.72M |
Baker bros. advisors lp | 7.28M | 6.86% | $51.73M |
Rtw investments, lp | 6.54M | 6.17% | $46.50M |
Vestal point capital, lp | 6.28M | 5.92% | $44.62M |
Paradigm biocapital advisors lp | 5.41M | 5.11% | $38.50M |
Suvretta capital management | 5.07M | 4.78% | $36.01M |
Orbimed advisors | 3.09M | 2.91% | $21.95M |
Goldman sachs group | 2.38M | 2.25% | $16.92M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Aquilo capital management | 373.90K | 4.01% | $2.66M |
Vestal point capital, lp | 6.28M | 2.65% | $44.62M |
Perceptive advisors | 9.38M | 1.84% | $66.72M |
University of texas/texas am investment managment | 697.43K | 1.58% | $8.10M |
Paradigm biocapital advisors lp | 5.41M | 1.34% | $38.50M |
Suvretta capital management | 5.07M | 1.23% | $36.01M |
Sphera funds management | 921.11K | 1.18% | $6.55M |
Rtw investments, lp | 6.54M | 0.70% | $46.50M |
Frazier life sciences management | 1.15M | 0.63% | $13.39M |
Baker bros. advisors lp | 7.28M | 0.55% | $51.73M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Suvretta capital management | 5.07M | 1.23% | 5.07M |
T. rowe price investment management | 10.60M | 0.05% | 3.23M |
Vestal point capital, lp | 6.28M | 2.65% | 2.52M |
Goldman sachs group | 2.38M | 0.00% | 2.27M |
Paradigm biocapital advisors lp | 5.41M | 1.34% | 1.51M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Braidwell lp | - | - | -3.50M |
Rtw investments, lp | 6.54M | 0.70% | -3.46M |
Price t rowe associates inc /md/ | - | - | -2.46M |
Vr adviser | - | - | -1.75M |
Logos global management lp | - | - | -1.00M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Frazier life sciences management | 1.15M | 0.63% | 1.15M | $13.39M |
Graham capital management | 18.34K | 0.00% | 18.34K | $130.38K |
Guggenheim capital | 14.21K | 0.00% | 14.21K | $101.03K |
Bnp paribas arbitrage, snc | 1.00 | - | 1.00 | $7.00 |
Sold Out
Holder | Change |
---|---|
Fmr | -1.00 |
American capital advisory | -6.00 |
Cibc private wealth group | -27.00 |
Clear street markets | -125.00 |
Us bancorp \de\ | -126.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 80 | -13.04% | 91,358,307 | -1.00% | 86 | 1.14% | 39 | -23.53% | 21 | -12.50% |
Dec 31, 2024 | 34 | -65.66% | 17,215,145 | -77.31% | 16 | 0.32% | 19 | -42.42% | 9 | -78.05% |
Sep 30, 2024 | 98 | 1.03% | 75,814,938 | -1.05% | 71 | 1.19% | 32 | -39.62% | 41 | 64.00% |
Jun 30, 2024 | 97 | 15.48% | 76,618,550 | 8.59% | 77 | 1.12% | 53 | 20.45% | 25 | -7.41% |
Mar 31, 2024 | 84 | -1.18% | 70,558,206 | 42.27% | 83 | 2.36% | 44 | -2.22% | 27 | 22.73% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Explorer Inv | 3.75M | 3.08% | - |
T. Rowe Price Small-Cap Value | 3.73M | 3.07% | -802.00 |
T. Rowe Price US Small-Cap Core Equity | 3.19M | 2.63% | 1.08M |
T. Rowe Price Small-Cap Stock | 3.19M | 2.63% | 277.75K |
T. Rowe Price U.S. SC Value Eq Tr-Z | 2.12M | 1.75% | 560.48K |
T. Rowe Price U.S. SC Value Eq Tr-D | 2.12M | 1.75% | 560.48K |
T. Rowe Price Instl Small-Cap Stock | 1.70M | 1.40% | 158.12K |
T. Rowe Price U.S. SC Core Eq Tr-Z | 1.48M | 1.22% | 366.35K |
T. Rowe Price U.S. SC Core Eq Tr-D | 1.48M | 1.22% | 366.35K |
US Small-Cap Growth II Equity Comp | 1.20M | 0.99% | -1.03K |
IMTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools